guest ::
| Home > Publications database > Compromised DNA repair is responsible for diabetes-associated fibrosis. > print |
| Home > Publications database > Compromised DNA repair is responsible for diabetes-associated fibrosis. > print |
| 001 | 166280 | ||
| 005 | 20240229123224.0 | ||
| 024 | 7 | _ | |a 10.15252/embj.2019103477 |2 doi |
| 024 | 7 | _ | |a pmid:32338774 |2 pmid |
| 024 | 7 | _ | |a pmc:PMC7265245 |2 pmc |
| 024 | 7 | _ | |a 0261-4189 |2 ISSN |
| 024 | 7 | _ | |a 1460-2075 |2 ISSN |
| 024 | 7 | _ | |a altmetric:80751805 |2 altmetric |
| 037 | _ | _ | |a DKFZ-2020-02773 |
| 041 | _ | _ | |a eng |
| 082 | _ | _ | |a 570 |
| 100 | 1 | _ | |a Kumar, Varun |0 0000-0003-2827-1024 |b 0 |
| 245 | _ | _ | |a Compromised DNA repair is responsible for diabetes-associated fibrosis. |
| 260 | _ | _ | |a Hoboken, NJ [u.a.] |c 2020 |b Wiley |
| 336 | 7 | _ | |a article |2 DRIVER |
| 336 | 7 | _ | |a Output Types/Journal article |2 DataCite |
| 336 | 7 | _ | |a Journal Article |b journal |m journal |0 PUB:(DE-HGF)16 |s 1607949663_3871 |2 PUB:(DE-HGF) |
| 336 | 7 | _ | |a ARTICLE |2 BibTeX |
| 336 | 7 | _ | |a JOURNAL_ARTICLE |2 ORCID |
| 336 | 7 | _ | |a Journal Article |0 0 |2 EndNote |
| 500 | _ | _ | |a 2020 Jun 2;39(11):e103477 |
| 520 | _ | _ | |a Diabetes-associated organ fibrosis, marked by elevated cellular senescence, is a growing health concern. Intriguingly, the mechanism underlying this association remained unknown. Moreover, insulin alone can neither reverse organ fibrosis nor the associated secretory phenotype, favoring the exciting notion that thus far unknown mechanisms must be operative. Here, we show that experimental type 1 and type 2 diabetes impairs DNA repair, leading to senescence, inflammatory phenotypes, and ultimately fibrosis. Carbohydrates were found to trigger this cascade by decreasing the NAD+ /NADH ratio and NHEJ-repair in vitro and in diabetes mouse models. Restoring DNA repair by nuclear over-expression of phosphomimetic RAGE reduces DNA damage, inflammation, and fibrosis, thereby restoring organ function. Our study provides a novel conceptual framework for understanding diabetic fibrosis on the basis of persistent DNA damage signaling and points to unprecedented approaches to restore DNA repair capacity for resolution of fibrosis in patients with diabetes. |
| 536 | _ | _ | |a 312 - Functional and structural genomics (POF3-312) |0 G:(DE-HGF)POF3-312 |c POF3-312 |f POF III |x 0 |
| 588 | _ | _ | |a Dataset connected to CrossRef, PubMed, |
| 650 | _ | 7 | |a DNA double-strand breaks |2 Other |
| 650 | _ | 7 | |a diabetes |2 Other |
| 650 | _ | 7 | |a nuclear isoform of the Receptor for Advanced Glycation End products |2 Other |
| 650 | _ | 7 | |a pulmonary fibrosis |2 Other |
| 650 | _ | 7 | |a reducing carbohydrates |2 Other |
| 700 | 1 | _ | |a Agrawal, Raman |b 1 |
| 700 | 1 | _ | |a Pandey, Aparamita |b 2 |
| 700 | 1 | _ | |a Kopf, Stefan |b 3 |
| 700 | 1 | _ | |a Hoeffgen, Manuel |b 4 |
| 700 | 1 | _ | |a Kaymak, Serap |b 5 |
| 700 | 1 | _ | |a Bandapalli, Obul Reddy |0 P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc |b 6 |u dkfz |
| 700 | 1 | _ | |a Gorbunova, Vera |b 7 |
| 700 | 1 | _ | |a Seluanov, Andrei |b 8 |
| 700 | 1 | _ | |a Mall, Marcus A |b 9 |
| 700 | 1 | _ | |a Herzig, Stephan |b 10 |
| 700 | 1 | _ | |a Nawroth, Peter P |0 0000-0002-6134-7804 |b 11 |
| 773 | _ | _ | |a 10.15252/embj.2019103477 |g Vol. 39, no. 11 |0 PERI:(DE-600)1467419-1 |n 11 |p e103477 |t The EMBO journal |v 39 |y 2020 |x 1460-2075 |
| 909 | C | O | |o oai:inrepo02.dkfz.de:166280 |p VDB |
| 910 | 1 | _ | |a Deutsches Krebsforschungszentrum |0 I:(DE-588b)2036810-0 |k DKFZ |b 6 |6 P:(DE-He78)b11ccde1801d45d32a6a60f7b396d7dc |
| 913 | 1 | _ | |a DE-HGF |b Gesundheit |l Krebsforschung |1 G:(DE-HGF)POF3-310 |0 G:(DE-HGF)POF3-312 |3 G:(DE-HGF)POF3 |2 G:(DE-HGF)POF3-300 |4 G:(DE-HGF)POF |v Functional and structural genomics |x 0 |
| 914 | 1 | _ | |y 2020 |
| 915 | _ | _ | |a DEAL Wiley |0 StatID:(DE-HGF)3001 |2 StatID |d 2020-09-11 |w ger |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0200 |2 StatID |b SCOPUS |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0300 |2 StatID |b Medline |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0320 |2 StatID |b PubMed Central |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0199 |2 StatID |b Clarivate Analytics Master Journal List |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1030 |2 StatID |b Current Contents - Life Sciences |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0160 |2 StatID |b Essential Science Indicators |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1050 |2 StatID |b BIOSIS Previews |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)1190 |2 StatID |b Biological Abstracts |d 2020-09-11 |
| 915 | _ | _ | |a WoS |0 StatID:(DE-HGF)0113 |2 StatID |b Science Citation Index Expanded |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0150 |2 StatID |b Web of Science Core Collection |d 2020-09-11 |
| 915 | _ | _ | |a JCR |0 StatID:(DE-HGF)0100 |2 StatID |b EMBO J : 2018 |d 2020-09-11 |
| 915 | _ | _ | |a DBCoverage |0 StatID:(DE-HGF)0600 |2 StatID |b Ebsco Academic Search |d 2020-09-11 |
| 915 | _ | _ | |a Peer Review |0 StatID:(DE-HGF)0030 |2 StatID |b ASC |d 2020-09-11 |
| 915 | _ | _ | |a IF >= 10 |0 StatID:(DE-HGF)9910 |2 StatID |b EMBO J : 2018 |d 2020-09-11 |
| 920 | 1 | _ | |0 I:(DE-He78)B062-20160331 |k B062 |l B062 Pädiatrische Neuroonkologie |x 0 |
| 980 | _ | _ | |a journal |
| 980 | _ | _ | |a VDB |
| 980 | _ | _ | |a I:(DE-He78)B062-20160331 |
| 980 | _ | _ | |a UNRESTRICTED |
| Library | Collection | CLSMajor | CLSMinor | Language | Author |
|---|